Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Renaissance Group LLC

Renaissance Group LLC lifted its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 36.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,384 shares of the company's stock after purchasing an additional 9,761 shares during the quarter. Renaissance Group LLC owned about 0.20% of Addus HomeCare worth $4,561,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ADUS. Quarry LP purchased a new position in Addus HomeCare in the third quarter valued at about $28,000. Smartleaf Asset Management LLC grew its stake in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after buying an additional 214 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after buying an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new position in Addus HomeCare during the 4th quarter worth approximately $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in Addus HomeCare in the 4th quarter worth approximately $86,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Stephens reissued an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie restated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Thursday. Finally, Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare presently has a consensus rating of "Moderate Buy" and a consensus target price of $132.78.

Remove Ads

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $0.92 during midday trading on Friday, hitting $100.85. 194,173 shares of the company's stock were exchanged, compared to its average volume of 163,692. Addus HomeCare Co. has a twelve month low of $87.88 and a twelve month high of $136.72. The firm has a market cap of $1.83 billion, a P/E ratio of 23.08, a PEG ratio of 1.41 and a beta of 0.93. The stock's 50 day moving average price is $101.16 and its 200-day moving average price is $117.97.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.